This consensus statement highlights the under-recognition and suboptimal treatment of cardiovascular disease in women and calls for optimized care and increased support for female interventional cardiologists.
Urgent adoption of sex-specific protocols needed to close CVD treatment gaps in women; extends consensus by guiding optimized care and equity research.
Cardiovascular disease (CVD) is the leading cause of mortality in women, yet studies have suggested that it is often under-recognized. Of particular concern is the apparent suboptimal treatment of women in comparison to men, with less revascularization and use of evidence-based medications. The Women in Innovations group of cardiologists aims to highlight these issues and change perceptions to optimize the treatment of female patients with CVD, to support future research, and to encourage and guide the training of female interventional cardiologists.
No takes yet. Share an insight, caveat, or question.
Chieffo et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: